Updates from The Motley Fool

Latest updates on Celldex Therapeutics from Fool.com.

Stock Performance

CLDX vs. S&P 500 | 2 Year Performance
CLDX 1-Day Stock Chart
CLDX 5-Day Stock Chart
CLDX 1-Month Stock Chart
CLDX 3-Month Stock Chart
CLDX 6-Month Stock Chart
CLDX 1-Year Stock Chart
CLDX 2-Year Stock Chart
CLDX 5-Year Stock Chart
View Interactive CLDX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Celldex Therapeutics.
Current Price: $4.33
Prev Close: $4.17
Open: $4.17
Bid: $4.16
Ask: $4.32
Day's Range: $4.09 - $4.34
52wk Range: $2.96 - $29.94
Volume: 1,449,548
Avg Vol 3,270,273
Market Cap: $427.14M
P/E (ttm): -3.26
EPS (ttm): -$1.33
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Celldex Therapeutics.
CAPS Rating 4 out of 5
366 Outperform
18 Underperform
CAPS All Stars
58 Outperform
8 Underperform

How do you think Celldex Therapeutics will perform against the market?

You pick for Celldex Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Anthony S. Marucci, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Celldex Therapeutics.

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers